Post-earnings recap
Reported
Tue, Mar 12, 2024
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
50%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Core Scientific Inc reported a significant loss per share, which was much worse than expected, leading to a 4.58% drop in stock price. The lack of revenue figures and guidance adds uncertainty for investors. Management's defensive tone suggests they are navigating a tough market and may need to reassess their strategies moving forward.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.51 | N/A | -1600.00% |
| Revenue | N/A | N/A | N/A |
Management expressed concerns about the current market environment and indicated that the company is focusing on long-term strategies. They did not provide specific guidance for the upcoming quarters.
Management acknowledged the challenging market conditions.
They emphasized the need for strategic adjustments moving forward.